The top 10 drug launches since 2017
FiercePharma ranks the top 10 drug launches since 2017 by sales for their first four full quarters on the market. Drugs approved toward the end of a quarter had a shorter period to rack up sales, but even taking that into consideration, the rankings were largely the same. See who made the list:
- Mavyret
- Biktarvy
- Ocrevus
- Shingrix
- Spinraza
- Skyrizi
- Zolgensma
- Ozempic
- Tremfya
- Dupixent
